Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 11, 2010 - Issue 13
Submit an article Journal homepage
296
Views
6
CrossRef citations to date
0
Altmetric
Clinical Trial Evaluation

Comparison of once-weekly with twice-daily exenatide in the treatment of type 2 diabetes (DURATION-1 trial)

Evaluation of: DURATION-1. Exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks. Diabetes Care 2010;33:1255-61

Philip Raskin
&
Alok Mohan University of Texas Southwestern, Department of Endocrinology, 5323 Harry Hines Blvd, Dallas MC8858, Texas 75219, USA [email protected]
Pages 2269-2271 | Published online: 10 Jun 2010

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Katherine V Mann & Philip Raskin. (2014) Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 7, pages 229-239.
Read now
Lindsay A Bischoff, Serge A Jabbour & Jeffrey L Miller. (2011) Exenatide once weekly in type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 12:8, pages 1297-1303.
Read now

Articles from other publishers (4)

Thomas B. Repas. (2014) Managing Loss of Glycemic Control in Middle-Aged Patients With Diabetes: The Role of GLP-1 Receptor Agonists in Combination-Therapy Regimens. Journal of Osteopathic Medicine 114:s52, pages 14-21.
Crossref
Jerry D. MeeceTeresa L. PearsonLinda M. Siminerio. (2014) Complementary Approaches to Improving Glucose Control—Insulin and Incretins. The Diabetes Educator 40:1_suppl, pages 4S-26S.
Crossref
Susan A Cornell. (2013) A patient-centred approach to treatment with incretin-based agents in patients with type 2 diabetes. Journal of Clinical Pharmacy and Therapeutics 38:3, pages 181-189.
Crossref
Y. Wang, L. Li, M. Yang, H. Liu, G. Boden & G. Yang. (2011) Glucagon-like peptide-1 receptor agonists versus insulin in inadequately controlled patients with type 2 diabetes mellitus: a meta-analysis of clinical trials. Diabetes, Obesity and Metabolism 13:11, pages 972-981.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.